Clinical Trial - Trial ChiCTR2100050400
Access comprehensive clinical trial information for ChiCTR2100050400 through Pure Global AI's free database. This Phase 2 trial is sponsored by Aerospace Center Hospital and is currently Recruiting. The study focuses on Leukemia.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
ChiCTR2100050400
Phase 2
Recruiting
Trial Details
Chinese Clinical Trial Registry • ChiCTR2100050400
View on Chinese Clinical Trial Registry
Untitled Trial
A prospective, single center, single arm, phase II clinical study of maintenance therapy with chidamide after allogeneic hematopoietic stem cell transplantation (allo HSCT) for high risk acute myeloid leukemia (HR AML)
Study Focus
Sponsor & Location
Aerospace Center Hospital
Self funded
China
Timeline & Enrollment
Phase 2
N/A
Dec 31, 2023
ICD-10 Classifications
Leukaemia, unspecified
Myeloid leukaemia
Myeloid leukaemia, unspecified
Other myeloid leukaemia
Monocytic leukaemia, unspecified
Data Source
Chinese Clinical Trial Registry
ChiCTR2100050400
Non-Device Trial